Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NV › Las Vegas › NPI 1528101284
Hospital

Dignity Health

Dignity Health was paid $7.93M by Medicaid between Jan 2018 and Dec 2024, across 178 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

33Billing provider infoDIGNITY HEALTH
LAS VEGAS, NV 89113
33aNPI1528101284assigned 02/14/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.93M
24GClaims557,047
24DCodes billed178
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Nevada

Rank by total paid#17 of 36
Median peer was paid$7.64M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MORISSETTE, DANIEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201842,656$377K
2019118,162$1.66M
202093,871$1.28M
202193,960$1.29M
202282,387$1.26M
202374,473$1.17M
2024incomplete51,538$894K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 19,125 14,974 $1.32M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 17% 14,172 10,658 $1.32M
74177 Computed tomography, abdomen and pelvis; with contrast material 9.6% 4,270 3,266 $763K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.8% 13,497 11,554 $616K
G0378 Hospital observation service, per hour 5.8% 8,273 4,111 $462K
70450 Computed tomography, head or brain; without contrast material 3.2% 4,554 3,458 $251K
71275 Computed tomographic angiography, chest, with contrast material 2.9% 1,230 939 $227K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.5% 15,401 11,039 $199K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.4% 1,823 1,386 $193K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.9% 6,155 4,760 $148K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.6% 426 285 $128K
96375 Therapeutic injection; each additional sequential IV push 1.5% 12,495 8,576 $123K
166 more codes
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1.4% 7,957 $111K
80053 Comprehensive metabolic panel 1.3% 30,070 $106K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 34,388 $89K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,247 $79K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,439 $78K
96376 <1% 4,950 $75K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,786 $73K
72125 Computed tomography, cervical spine; without contrast material <1% 924 $71K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,112 $67K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,583 $64K
71045 Radiologic examination, chest; single view <1% 13,153 $63K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,639 $61K
83880 <1% 6,536 $58K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 17,007 $56K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 3,868 $49K
84484 <1% 13,254 $49K
99070 <1% 5,287 $48K
J3490 Unclassified drugs <1% 19,885 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 924 $41K
96361 Intravenous infusion, hydration; each additional hour <1% 4,644 $41K
J7030 Infusion, normal saline solution , 1000 cc <1% 19,868 $38K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,147 $36K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 620 $35K
71046 Radiologic examination, chest; 2 views <1% 3,595 $32K
84703 <1% 10,849 $31K
J2785 Injection, regadenoson, 0.1 mg <1% 441 $31K
83690 <1% 11,138 $27K
87040 <1% 3,471 $26K
0450 Emergency room services <1% 522 $24K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 117 $20K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 149 $19K
J2270 Injection, morphine sulfate, up to 10 mg <1% 10,243 $19K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 429 $18K
83605 <1% 4,984 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 8,495 $18K
76801 <1% 288 $16K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 439 $16K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,011 $16K
36415 Collection of venous blood by venipuncture <1% 24,600 $16K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,970 $15K
83735 <1% 7,818 $14K
93971 <1% 358 $14K
59025 Fetal non-stress test <1% 499 $14K
76830 Ultrasound, transvaginal <1% 200 $13K
97161 <1% 1,265 $13K
74022 <1% 562 $12K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,735 $12K
85379 <1% 3,104 $12K
85610 <1% 10,997 $11K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 679 $11K
81001 <1% 10,639 $11K
84443 Thyroid stimulating hormone (TSH) <1% 2,417 $11K
85730 <1% 7,335 $11K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,639 $11K
82550 <1% 5,057 $10K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 515 $9K
72131 <1% 87 $9K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 409 $9K
87088 <1% 2,820 $8K
99213 Doctor's office visit, returning patient (routine) <1% 343 $7K
85027 <1% 4,281 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 363 $7K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 363 $7K
84702 <1% 965 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,297 $6K
J1815 Injection, insulin, per 5 units <1% 2,449 $6K
81025 <1% 2,499 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,761 $5K
97165 <1% 492 $5K
84100 <1% 3,724 $5K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,900 $5K
93017 <1% 429 $4K
81003 <1% 5,336 $4K
93970 <1% 68 $4K
82962 <1% 5,884 $4K
80061 Lipid panel <1% 1,255 $4K
87077 <1% 1,328 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 1,714 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,598 $3K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,200 $3K
J0780 Injection, prochlorperazine, up to 10 mg <1% 399 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 56 $3K
73030 <1% 219 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 402 $2K
86901 <1% 2,557 $2K
86703 <1% 328 $2K
J2060 Injection, lorazepam, 2 mg <1% 3,065 $2K
73630 <1% 128 $2K
87070 <1% 318 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,350 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 332 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 394 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 916 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,797 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 2,108 $2K
73610 <1% 72 $1K
90715 <1% 45 $1K
74018 <1% 125 $1K
80320 <1% 1,524 $1K
86850 <1% 1,787 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 104 $1K
87081 <1% 470 $1K
86900 <1% 1,798 $1K
82805 <1% 132 $1K
73130 <1% 67 $1K
J3370 Injection, vancomycin hcl, 500 mg <1% 107 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 323 $1K
J2704 Injection, propofol, 10 mg <1% 2,997 $965.55
73564 <1% 51 $947.81
70551 Magnetic resonance imaging, brain; without contrast material <1% 17 $945.36
86140 <1% 609 $945.02
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,618 $920.90
94644 <1% 79 $894.57
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 267 $861.95
85007 <1% 979 $860.96
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 17 $645.86
86592 <1% 325 $634.23
J0690 Injection, cefazolin sodium, 500 mg <1% 1,086 $622.51
87631 <1% 303 $589.61
84145 <1% 66 $562.23
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 148 $554.63
82728 <1% 144 $451.64
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 303 $443.64
87205 <1% 494 $438.10
84439 <1% 185 $412.56
J1630 Injection, haloperidol, up to 5 mg <1% 253 $401.77
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 88 $369.24
97162 <1% 26 $352.75
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 251 $337.50
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 257 $334.80
80329 <1% 365 $298.05
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,624 $269.47
G0379 Direct admission of patient for hospital observation care <1% 494 $267.35
85652 <1% 304 $265.91
J3475 Injection, magnesium sulfate, per 500 mg <1% 285 $254.98
C9113 Injection, pantoprazole sodium, per vial <1% 617 $199.89
J1790 Injection, droperidol, up to 5 mg <1% 47 $194.81
80069 <1% 314 $172.90
87210 <1% 75 $143.86
83615 <1% 70 $130.04
82010 <1% 33 $117.18
86735 <1% 13 $105.02
87807 <1% 12 $99.80
64488 <1% 60 $73.92
82140 <1% 15 $59.64
99153 Mod sedat endo service >5yrs <1% 35 $56.55
90658 <1% 14 $54.60
99152 <1% 35 $45.37
A9270 Non-covered item or service <1% 6,508 $43.37
J8540 Dexamethasone, oral, 0.25 mg <1% 18 $29.96
J1171 Injection, hydromorphone, 0.1 mg <1% 40 $29.93
82553 <1% 19 $23.64
88304 <1% 20 $20.20
J3480 Injection, potassium chloride, per 2 meq <1% 23 $17.42
84132 <1% 24 $12.56
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 34 $2.00
00731 0% 80 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 91 $0.00
88312 0% 18 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 90 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 145 $0.00
C9399 Unclassified drugs or biologicals 0% 46 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 58 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 49 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 39 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORISSETTE, DANIEL (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
Same official

Other billing entities under MORISSETTE, DANIEL

Full network →
ProviderLocationPaid
Dignity HealthSan Bernardino, CA$133.09M
Dignity HealthPhoenix, AZ$126.19M
Dignity HealthBakersfield, CA$109.22M
Dignity HealthMerced, CA$106.54M
Dignity HealthCarmichael, CA$97.28M
Dignity HealthOxnard, CA$96.24M
Dignity HealthRedding, CA$92.21M
Dignity HealthLong Beach, CA$59.98M
Dignity HealthSacramento, CA$45.52M
Dignity HealthFolsom, CA$45.14M
Dignity HealthRed Bluff, CA$39.92M
Dignity HealthSanta Cruz, CA$33.59M
Dignity HealthGilbert, AZ$28.49M
Dignity HealthGlendale, AZ$26.30M
Dignity HealthHenderson, NV$18.73M
Dignity HealthMount Shasta, CA$15.62M
Dignity HealthHenderson, NV$8.52M
Dignity HealthCamarillo, CA$6.31M
Dignity HealthSanta Maria, CA$5.79M
Dignity HealthCorning, CA$3.24M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.